Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ACB-H82E3 | Human | Biotinylated Human Activin RIIB Protein, His,Avitag™ |
|
|
|
ACB-H5226 | Human | Human Activin RIIB / ACVR2B Protein, His Tag |
|
|
Biotinylated Human Activin RIIB Protein, His,Avitag (Cat. No. ACB-H82E3) immobilized on CM5 Chip can bind Human Latent Activin A, His Tag (Cat. No. ACA-H424x) with an affinity constant of 0.147 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
BIIB-110 | ALG-801; BIIB-110 | Phase 1 Clinical | Biogen Inc, Alivegen USA Inc | Muscular Atrophy, Spinal | Details |
Bimagrumab | BYM-338 | Phase 2 Clinical | Morphosys Ag, Novartis Pharma Ag | Diabetes Mellitus, Type 2; Myositis, Inclusion Body; Pulmonary Disease, Chronic Obstructive; Obesity; Sarcopenia | Details |
This web search service is supported by Google Inc.